Bridgeway Capital Management’s Acorda Therapeutics ACOR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,835	Closed	-$45K	–	1484
2023 Q1	$45K	Hold	3,835	–	–	﹤0.01%	1317
2022 Q4	$58.8K	Sell	3,835 -1,250	-25%	-$14.6K	﹤0.01%	1283
2022 Q3	$30K	Hold	5,085	–	–	﹤0.01%	1376
2022 Q2	$47K	Sell	5,085 -7,120	-58%	-$127K	﹤0.01%	1287
2022 Q1	$393K	Hold	12,205	–	–	0.01%	1000
2021 Q4	$583K	Buy	12,205 +5,175	+74%	+$357K	0.01%	938
2021 Q3	$647K	Buy	7,030 +1,950	+38%	+$162K	0.01%	959
2021 Q2	$485K	Buy	5,080 +1,559	+44%	+$136K	0.01%	1073
2021 Q1	$343K	Buy	3,521 +2,150	+157%	+$264K	0.01%	1199
2020 Q4	$114K	Sell	1,371 -755	-36%	-$69.4K	﹤0.01%	1261
2020 Q3	$131K	Sell	2,126 -750	-26%	-$56.6K	﹤0.01%	1233
2020 Q2	$254K	Buy	2,876 +1,292	+82%	+$137K	0.01%	1085
2020 Q1	$177K	Sell	1,584 -1,225	-44%	-$241K	﹤0.01%	1090
2019 Q4	$688K	Buy	2,809 +1,167	+71%	+$294K	0.01%	843
2019 Q3	$565K	Hold	1,642	–	–	0.01%	909
2019 Q2	$1.51M	Sell	1,642 -166	-9%	-$204K	0.02%	621
2019 Q1	$2.88M	Hold	1,808	–	–	0.04%	395
2018 Q4	$3.38M	Buy	+1,808	New	+$3.93M	0.04%	293